NCT00105430

Brief Summary

This study will evaluate the effectiveness of deep brain stimulation (DBS) in treating primary generalized dystonia. Patients with dystonia have muscle spasms that cause uncontrolled twisting and repetitive movement or abnormal postures. Medical therapies are available, but not all patients get adequate relief from the abnormal movements or the pain associated with them. DBS is a surgical procedure that interrupts neuronal circuits in the Gpi and STN, areas of the basal ganglia of the brain that do not work correctly in patients with dystonia. The surgery results in decreased movement and therefore may lessen patients' symptoms and pain. Patients 7 years of age and older with generalized dystonia that does not respond to medical treatment may be eligible for this study. Candidates are screened with blood and urine tests, chest x-ray, and an electrocardiogram in patients 35 years of age or more. Participants undergo the following tests and procedures:

  • Magnetic resonance imaging. MRI uses a magnetic field and radio waves to produce images of the brain. The patient lies on a table that is moved into the scanner (a narrow cylinder), wearing earplugs to muffle loud knocking and thumping sounds that occur during the scanning process. The procedure usually lasts about 45 to 90 minutes, during which the patient is asked to lie still for up to 15 minutes at a time.
  • Transcranial magnetic stimulation. This procedure maps brain function. A wire coil is held on the scalp, and a brief electrical current is passed through the coil, creating a magnetic pulse that stimulates the brain. During the stimulation, the patient may be asked to tense certain muscles slightly or perform other simple actions. The stimulation may cause a twitch in muscles of the face, arm, or leg, and the patient may hear a click and feel a pulling sensation on the skin under the coil. During the stimulation, electrical activity of muscles is recorded with a computer, using electrodes attached to the skin with tape.
  • Neurologic evaluation. Before and after DBS, the patient's dystonia, including voice strength and difficulty swallowing, are measured with a standardized rating scale.
  • DBS treatment. Patients are randomly assigned to have electrodes implanted in either the Gpi or STN area of the basal ganglia. The electrodes are what stimulate the brain in DBS therapy. Before surgery, a frame is secured to the patient's head, and an MRI scan is done. DBS involves making two small incisions and two small holes in the skull, opening the lining around the brain, locating the Gpi or STN, securing the electrodes in place and connecting them to the pulse generator that is placed under the skin below the collar bone. Additionally, during the surgery, the patient is asked to move certain muscles. The muscle activity is recorded to gain a better understanding of the physiology of movement. After surgery, computed tomography (CT) and MRI scans are done to confirm placement of the electrodes.
  • Stimulation and evaluation. After surgery, patients' movements are evaluated during and after stimulation. The changes in movement and function are videotaped and scored according to a rating scale. The optimal stimulation settings are determined and the stimulators are adjusted accordingly.
  • Follow-up. Patients are evaluated, with videotaping, at 1, 2, 3, 6, 12, 18 and 24 months after surgery, and the stimulators are adjusted as needed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Mar 2005

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2005

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

March 11, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 14, 2005

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2006

Completed
Last Updated

July 6, 2006

Status Verified

July 1, 2006

First QC Date

March 11, 2005

Last Update Submit

July 4, 2006

Conditions

Keywords

SurgeryTreatmentPhysiologyPediatricNeurosurgeryGeneralized Primary Dystonia

Outcome Measures

Primary Outcomes (1)

  • Clinical effectiveness of DBS of the Gpi or STN will be measured by the Burke-Fahn-Marsden Scale (BFM) and monitored over time to determine the effectiveness DBS and if there is an ideal anatomic stimulation site.@@@@@@@@@

Secondary Outcomes (1)

  • Determine the underlying pathophysiology of dystonia, and the mechanism of action of DBS.

Interventions

Eligibility Criteria

Age7 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • To be eligible for entry into the study, candidates must meet all the following criteria:
  • Patients greater than 7 years of age with generalized primary dystonia.
  • Patients who are refractory to medical treatment (including levodopa, anticholinergics, benzodiazepines, Baclofen) who are considered surgical candidates. Patients will be determined to have medical refractory dystonia after having been treated by at least two medications of two different groups at the maximum recommended dose for a duration of at least two months.
  • In case of treatment by intrathecal Baclofen delivered by a pump, a change to oral Baclofen must be performed, so that the pump can be taken out.
  • Patients must have a minimum BFM score of 20 on optimal medical therapy.
  • Adults must be mentally competent to consent for entrance into the protocol at the time of admission.
  • Patients must have a signed DPA for research purposes.

You may not qualify if:

  • Candidates will be excluded if:
  • The patient has had previous lesioning surgery including radiofrequency lesioning of deep nuclei (thalamus, pallidum, STN).
  • The patient currently has a functioning and effective stimulator in deep brain nuclei (thalamus, pallidum, STN).
  • The patient is not able to tolerate surgery, as determined by the preoperative evaluation.
  • The patient has a coagulopathy demonstrated by an abnormal prothrombin time, activated partial thromboplastin time, or thrombocytopenia (platelet count less than 150,000 platelets/mm(3)).
  • The patient has an acute or untreated infection (viral, bacterial or fungal).
  • The patient has a contraindication to MR-imaging such as previous surgery that involved placement of metal objects that could cause tissue damage or produce image artifacts.
  • The patient has another chronic neurologic disorder.
  • The patient is pregnant at the time of surgery.
  • The patient has epilepsy.
  • The patient does not have access to proper follow-up care at home and may not be eligible for the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Neurological Disorders and Stroke (NINDS)

Bethesda, Maryland, 20892, United States

Location

Related Publications (1)

  • Sanger TD, Garg RR, Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol. 2001 Jan 15;530(Pt 2):307-17. doi: 10.1111/j.1469-7793.2001.0307l.x.

    PMID: 11208978BACKGROUND

MeSH Terms

Conditions

Dystonia

Interventions

Deep Brain Stimulation

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
phase 2
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

March 11, 2005

First Posted

March 14, 2005

Study Start

March 1, 2005

Study Completion

July 1, 2006

Last Updated

July 6, 2006

Record last verified: 2006-07

Locations